Background: Atrial arrhythmias, particularly atrioventricular nodal reentrant tachycardia, can coexist with drug-induced type 1 Brugada electrocardiogram (ECG) pattern (DI-Type1-BrP). The present study was designed to determine the prevalence of DI-Type1-BrP in patients with atrioventricular accessory pathways (AV-APs) and to investigate the clinical, electrocardiographic, electrophysiologic, and genetic characteristics of these patients.
INTRODUCTION
Brugada syndrome (BrS) is an inherited cardiac arrhythmia syndrome characterized by a distinct ST-segment elevation in the right precordial leads in the absence of structural heart disease. 1 Type-1 ("coved type") ST-segment elevation is considered diagnostic of BrS and it is present either spontaneously or induced by fever or by sodium channel blockers. 2 Drug-induced type 1 Brugada electrocardiogram (ECG) pattern (DIType 1 BrP) has been shown to be associated with atrial arrhythmias, atrioventricular nodal reentrant tachycardia (AVNRT) in particular. 3 supraventricular tachycardia (PSVT), including Wolff-Parkinson-White (WPW) syndrome and concealed atrioventricular accessory pathways (AV-APs) with spontaneous atrioventricular reentrant tachycardia (AVRT), compared to the general population (1.7% vs ∼0.09%). [4] [5] [6] In view of this association, we hypothesized that a BrP phenotype may be more easily unmasked in patients with AV-APs. The present study was designed to determine the prevalence of DI-Type 1 BrP in patients with AV-APs and to investigate the clinical, electrocardiographic, electrophysiologic, and genetic characteristics of these patients.
METHODS

Study populations
One hundred twenty-four consecutive patients (50 women/74 men; mean age 36.4 ± 12.6 years; range 18-75) with AV-APs who underwent electrophysiologic study and catheter ablation between November 2011 and July 2017 formed the patient population and their characteristics were compared with a control group (n = 84, 42 women/42 men; mean age 39 ± 11.3 years; range 18-63). All patients and control subjects underwent an ajmaline challenge test. All study subjects were of Turkish (Anatolian Caucasian) descent. Study protocol was approved by the ethics committee of Ege University School of Medicine. Written informed consent was obtained from all patients for ajmaline challenge test and genetic testing.
Data acquisition
A detailed medical history including age of onset of AVRT and/or preexcited atrial fibrillation (AF), age at time of coincidentally detected preexcitation, associated symptoms (palpitation, chest pain, syncope, and cardiac arrest), and presence of systemic diseases (systemic hypertension, diabetes mellitus, migraine headaches) was obtained in all patients. Syncope was classified as reflex (vasovagal or situational), orthostatic hypotension, arrhythmia-related cardiac syncope, and unexplained syncope. The diagnosis of migraine headache was based on the international classification of headache disorders-II criteria. 7 Presence of additional atrial (preexcited AF All study subjects underwent transthoracic echocardiography for evaluation of valves, right and left ventricular size, and function.
Definition of electrocardiographic parameters
WPW syndrome was defined as ventricular preexcitation in the presence of spontaneous and/or inducible AVRT or spontaneous preexcited AF. 8 WPW "pattern" was defined as coincidentally detected ventricular preexcitation. Concealed AV-AP was defined as an accessory pathway which conducts only in retrograde direction resulting in normal QRS complex during sinus rhythm. 8 Prior to catheter ablation, all patients had a baseline 12-lead ECG analysis for measurements of heart rate, PR interval, QRS duration, and frontal plane QRS axis. All available, prior 12-lead ECGs from patients with preexcitation were analyzed for QRS fragmentation and early repolarization patterns (notching/slurring) in the inferior, lateral, and right precordial (V 1 -V 2 ) leads; QRS fragmentation in V 2 ; QR/rSr' pattern in V 1 with and without ST-segment elevation (≥0.05 mV); and QRS notching/slurring (≥0.1 mV) in lead aVL.
After successful catheter ablation, all patients had a 12-lead ECG with leads in the standard lead position and a high precordial lead ECG with V 1 and V 2 moved up to the third and second intercostal space. 2 Twelve-lead ECGs were checked for the presence of types 1, 2, and 3
BrP, QRS fragmentation, and early repolarization patterns in the inferior and lateral leads. Type 1 BrP, QRS fragmentation, and early repolarization patterns were defined according to previously described criteria. 2, 9, 10 Every patient had a 12-lead ECG during their index clinical arrhythmia. Twelve-lead ECGs during orthodromic AVRTs were analyzed for the rate of AVRT, the timing of the P-wave with respect to QRS complex, presence of aberrancy and QRS alternans, rSr' pattern in V 1 -V 2 , and QRS notching/slurring (≥0.1 mV) in lead aVL. 8 
Electrophysiologic study and catheter ablation
All patients underwent electrophysiologic study and catheter ablation for AV-APs. The diagnosis of AVRT was made based on previously described criteria. 8 Baseline AH and HV intervals during preexcitation, antegrade and retrograde AV-AP effective refractory periods, 1:1 AV-AP antegrade conduction, direction of conduction of AV-APs, presence of multiple AV-APs, rate of AVRT, and postablation AH and HV intervals were determined in each patient. Location of AV-APs was determined based on previously described criteria. 11 Radiofrequency energy was used as the energy source in all patients.
Definition of drug-induced type 1 Brugada ECG pattern and BrS
Type 1 BrP in at least one right precordial lead during ajmaline challenge test was defined as DI-Type 1 BrP. 2 BrS was defined according to the J-Wave syndromes expert consensus conference report. 2 
Definition of control group
The control group is an extension of our previously described control group (n = 66) with 18 additional enrolled subjects. 3 The control group consisted of unrelated subjects with structurally normal hearts and no history of any type of atrial arrhythmia including AVRT, AVNRT, or any form of ventricular arrhythmia.
Ajmaline challenge test
Ajmaline (Gilurytmal R , CARINOPHARM GmbH, Elze, Germany) challenge test was performed according to the J-Wave syndromes expert consensus conference report. 2 Ajmaline was administered as continuous intravenous infusion at a rate of 1 mg/kg body weight over 5 minutes. Criteria for discontinuation of ajmaline infusion were the development of diagnostic type 1 BrP, ventricular arrhythmias, or QRS widening to ≥130% of baseline. Patients with AV-APs underwent ajmaline challenge the following day after the electrophysiologic study and catheter ablation. All tests were performed by the same investigator in the same center using the same equipment with the same standard settings. Twelve-lead ECG recordings were performed by a standard electrocardiograph (ECG-9132K, Nihon Kohden Corporation, Tokyo, Japan) with standard settings (paper speed of 25 mm/s and a gain setting of 10 mm/mV) and summary report (showing median P-QRS-T complexes for each lead) in all subjects. PR and corrected QT intervals, QRS duration, and QRS axis were automatically analyzed, and P-wave duration was measured manually in lead II at baseline and after ajmaline challenge.
Genetic screening and in silico functional prediction of variants
Genetic screening and analysis was performed in 55 patients (24 women/31 men; mean age 37 ± 13 years): 19 with DI-Type 1 BrP and 36 without DI-Type 1 BrP. A total of 33 genes for BrS (ABCC9,   CACNA1C, CACNA2D1, CACNB2, CAV3, FGF12 [FHAF1], GPD1L,   HCN4, HEY2, KCNB2, KCND3, KCNE1-5, KCNH2, KCNJ8, KCNJ16,   KCNT1, PKP2, RANGRF [encodes MOG1], SCN1B-3B, SCN4A,   SCN5A, SCN9A, SCN10A, SCNN1A, SEMA3A, SLMAP, TRPM4) 
Statistical analysis
Values are expressed as range and mean ± standard deviation. Differences between means were tested by t-test, or Mann-Whitney test, where appropriate. Categorical variables were compared using 2 analysis or Fisher's exact test. Pearson's correlation coefficient was calculated for the relationship of two numeric data. P < 0.05 (two-sided) was considered statistically significant.
RESULTS
Prevalence of drug-induced type 1 Brugada ECG pattern and patient characteristics
DI-Type 1 BrP was detected in 20 out of 124 (16.1%) patients with AVAPs, and in four out of 84 control subjects (4.8%) (odds ratio 3.84; 95% confidence interval 1.265-11.698; P = 0.012).
The patient population was matched to the control group in terms of age (36.4 ± 12.6 years vs 39 ± 11.3 years, P = 0.133), male gender (59.7% vs 50%, P = 0.168), and left ventricular ejection fraction (62.8 ± 4.6% vs 64.5 ± 3.9%, P = 0.061). The patient population presented with a higher prevalence of palpitations (89.5% vs 8.3%, P ≤ 0.001) and migraine headaches (31.5% vs 19%, P = 0.047) compared to the control group. The prevalence of chest pain (12.9% vs 13.1%, P = 0.968) and syncope (15.3% vs 15.5%, P = 0.976) were similar between the patient population and the control group.
Patients with DI-Type 1 BrP had higher prevalence of chest pain (35% vs 8.7%, P = 0.001) and tendency to have higher prevalence of migraine headaches (50% vs 27.9%, P = 0.051) compared to patients without DI-Type 1 BrP. Mean age (39.1 ± 13.8 years vs 35.9 ± 12.4 years, P = 0.304), mean age of diagnosis of palpitation/AVRT/preexcited AF (27 ± 13.3 years vs 25.7 ± 11.3 years, P = 0.678), male gender (55% vs 60.6%, P = 0.641), prevalence of palpitations (85% vs 90.4%, P = 0.472), prevalence of syncope (25% vs 
Baseline 12-lead ECG and electrophysiologic characteristics
All patients were in normal sinus rhythm. Clinical and electrophysiologic characteristics of patients with DI-Type 1 BrP are presented in Table 1 . A comparison of baseline 12-lead ECG characteristics during preexcitation and AV-AP characteristics in patients with and without DI-type 1 BrP is presented in Table 2 . The median number of avail- 
TA B L E 2
Comparison of electrocardiographic and electrophysiologic characteristics of patients with and without drug-induced type 1 Brugada ECG pattern at baseline and during atrioventricular reentrant tachycardia The prevalence of spontaneous and clinical preexcited AF (5% vs 14.4%, P = 0.250) and history of AF (15% vs 18.3%, P = 0.726) prior to catheter ablation were similar in patients with and without DI-type 1 BrP (Table 2) .
None of the patients in the study population had spontaneous type 1 BrP on baseline, standard 12-lead ECGs during preexcitation or after successful catheter ablation. The prevalence of type 2 or 3 BrP after successful catheter ablation (20% vs 8.8%, P = 0.139) was not different in patients with and without DI-type 1 BrP, respectively. None of the patients in the study population developed ventricular fibrillation (VF) during catheter ablation of the accessory pathway.
Twelve-lead ECG characteristics during orthodromic AVRT
A comparison of 12-lead ECG characteristics during orthodromic AVRT in patients with and without DI-type 1 BrP is presented in 
Ajmaline challenge test characteristics
Patients with DI-type 1 BrP had more pronounced PR interval prolongation (54. 
Genetic characteristics
The prevalence of putative mutations in BrS susceptibility genes was higher in patients with DI-type 1 BrP compared to patients without Table 1 ) with drug-induced type 1 Brugada pattern. Patient 1 with a left posteroseptal accessory pathway had accentuated QRS notching in V 2 (arrow) with more pronounced preexcitation (A) compared to attenuated QRS notching in V 2 (arrow) with lesser degree of preexcitation (B) with similar heart rates. Patient 10 with a left posterolateral accessory pathway had accentuated QRS slurring/notching in V 2 (arrow) and aVL (arrow head) with more pronounced preexcitation (C) compared to disapperance of QRS slurring in V 2 and attenuated QRS slurring in aVL (arrow head) with lesser degree of preexcitation and faster heart rate (D). Patient 14 with a left posterior accessory pathway had accentuated QRS slurring in V 2 (arrow) and aVL (arrow head) with slower heart rate (E) compared to attenuated QRS slurring/notching in V 2 and unchanged QRS slurring in aVL (arrow head) with faster heart rate and similar degree of preexcitation (F). All electrocardiograms were recorded at a paper speed of 25 mm/s and a gain setting of 10 mm/mV. HR = heart rate
F I G U R E 3 Twelve-lead electrocardiograms during O-AVRT (A), at baseline (B), and after ajmaline challenge test (C). Patient was a 42-year-old
female who presented with a 10-year history of paroxysmal supraventricular tachycardia (Patient 10 in Table 1 ). She had structurally normal heart. She had rSr' pattern in V 1 Table 3 . One out of 19 (5.2%) patients with DI-type 1 BrP was also found to carry a second potentially pathogenic BrS mutation (Table 3) . Due to the lack of availability of family members, it is uncertain which genetic variant (or both) is causative in this case where two variants were uncovered.
DISCUSSION
AV-APs are the second most common cause of PSVT. 8 The coexis- 
Epidemiology of DI-type 1 BrP
The prevalence of DI-type 1 BrP among patients presenting primarily with AV-APs was 16.1% in our study population. This high prevalence has important implications in terms of epidemiology of DI-type 1
BrP. The prevalence of PSVT (AVNRT and AVRT) in the general population in the United States is reported to be approximately 2.25/1,000 individuals. 6 If these results could be extrapolated to the entire U.S. The worldwide prevalence of a Brugada ECG pattern (types 1, 2, and 3) in the general population is estimated to be 0.5 to 1.6 per 1,000. 2 The prevalence of DI-type 1 BrP in the general population is unknown. Table 1 ). She had structurally normal heart. Coronary sinus pacing with a rate of 650 ms resulted in loss of her preexcitation (arrow) with rS waves in V 1 and V 2 (A). Right after stopping coronary sinus pacing, a catheter-induced premature atrial contraction (asterisk) initiated O-AVRT (rate of 290 ms) with rSr' pattern in V 1 and V 2 (arrows) without ST-segment elevation (B). Electrophysiologic study revealed a right anterolateral accessory pathway conducting in antegrade and retrograde directions. She underwent successful accessory pathway ablation. Genetic analysis did not reveal any mutation in screened Brugada-susceptibility genes. Ajmaline challenge test resulted in prolongation of PR interval (235 ms), QRS duration (130 ms) with nonspecific intraventricular conduction delay , QRS axis of 50 • , and type 1 Brugada pattern in V 1 and V 2 . Lead V 3 through V 6 were not recorded during electrophysiologic study because of placement of a cardioversion patch in that region. O-AVRT = orthodromic atrioventricular reentrant tachycardia asymptomatic patients is 2%, suggesting that fever-induced type 1 BrP is more prevalent than previously thought. 13 QRS notching/slurring in V 2 and/or in lead aVL have been found to be dynamic and are typically accentuated with higher degrees of preexcitation ( Figure 2 ). Since the degree of preexcitation and newly described 12-lead ECG characteristics are dynamic findings, it is important to review of all available, prior 12-lead ECGs for these characteristics.
Clinical relevance of DI-type 1 BrP
Twelve-lead ECG characteristics during preexcitation
Prevalence of early repolarization pattern is reported to be ∼40-50% in patients with WPW syndrome prior to catheter ablation. 17 Following ablation of the accessory pathway, early repolarization pattern persists in 25% of patients, disappears in 18% of patients, and appears de novo in 10-15% of patients. 17 The clinical and prognostic significance of the high prevalence of early repolarization in patients with WPW syndrome is currently unknown.
In our study, patients with DI-Type 1 BrP had a higher prevalence of an rSr' in V 1 (31.2% vs 10.9%) after successful catheter ablation compared to patients without DI-type 1 BrP. Therefore, an rSr' pattern in V 1 during preexcitation is due in part to the presence of an rSr' pattern during sinus rhythm after catheter ablation. Other potential cause(s)
for an rSr' pattern in V 1 include higher placement of electrodes in V 1 -V 2 and J-point elevation. Prevalence of QRS notching/slurring in aVL (68.8% vs 34.2%) but not in V 2 (25% vs 11%) after successful catheter ablation was significantly higher in patients with DI-type 1 BrP compared to patients without DI-type 1 BrP. Therefore, the higher prevalence of QRS notching/slurring in aVL during preexcitation is due in part to the higher prevalence of QRS notching/slurring in aVL during sinus rhythm after catheter ablation in patients with DI-type 1 BrP. Our finding suggests that preexcitation is associated with underlying QRS notching/slurring, particularly in V 2 .
Twelve-lead ECG characteristics during orthodromic AVRT
Overall, patients with orthodromic AVRT typically have certain characteristics on 12-lead ECG including separation of P-waves (>90 ms)
from QRS complexes (∼80%), ST-segment depression (≥2 mm), and/or T-wave inversions (∼60%) and QRS alternans (∼20-25%). 8 In addition to these previously described 12-lead ECG characteristics, our study population with DI-type 1 BrP had higher prevalence of rSr' pattern in V 1 -V 2 and QRS notching/slurring in lead aVL during orthodromic AVRT compared to patients without DI-Type 1 BrP (Figures 3 and 4 ). vagal influences. 18 Retrograde P waves distorting the QRS complex is probably an unlikely explanation since the P waves during orthodromic AVRT often located further away from the QRS complexes.
DI-type 1 BrP: the link between AV-APs and occurrence of spontaneous, clinical AF?
Patients with AV-APs have an increased propensity to develop AF. 19 Male gender, older age, multiple AV-APs, presence of preexcitation and spontaneous AVRT, presence of structural heart disease, intrinsic atrial vulnerability due to developmental defects, and arrhythmogenic pul- development of AF in patients with BrS has been extensively studied. 20 Because of the lack of long-term follow-up, we are unable to determine definitively whether patients with DI-type 1 BrP and AV-APs are more or less prone to develop AF. 
J-point elevation and appearance of type 1 BrP during catheter ablation of AV-APs
It was recently reported that J-point elevation and type 1 BrP associated with polymorphic ventricular tachycardia and/or VF can be induced (in the presence of normal coronary arteries) by catheter ablation of AV-APs. 26 The study included four patients (2 M/2 F, age range 21-72 years) all with left-sided accessory pathways undergoing catheter ablation. 26 Each patient developed chest pain during radiofrequency catheter ablation of the AV-APs followed by J-point elevation, 
Genetics and the mechanistic link between AV-APs and DI-type 1 BrP
AV-AP formation underlying ventricular preexcitation seem to arise as a consequence of erroneous development of the AV canal myocardium. [27] [28] [29] After the formation of the primitive heart tube during early embryonic development, the AV canal myocardium develops between the atrial and ventricular myocardium. The AV canal myocardium gives rise to several cardiac components, including the future AV valves, ventricular septum, outflow tracts, and atrial part of the AV conduction axis. Notch and Wnt/ -catenin signaling pathways, transcription factors such as Tbx5/Tbx3/Tbx2, Hey1/Hey2, BMP2/4, Gata4, and Nkx2.5 play a regulatory role in the normal patterning and functional maturation of the AV canal myocardium. [27] [28] [29] Activation of Notch signaling and Tbx2 deficiency within murine myocardium result in AV-AP formation and ventricular preexcitation, similar to WPW syndrome. [27] [28] [29] It is tempting to speculate that the genetic defects giving rise to the accessory pathways during embryological development also predispose the RVOT to development of the substrate for BrS. 30 Genetic variants in proteins in the signaling pathways and/or transcription factors can potentially cause DI-type 1 BrP or BrS. 31, 32 Lossof-function mutation in Tbx5 (G145R) has been shown to cause BrS in humans. 31 Tbx5 and Tbx3 have been also shown to regulate the BrS susceptibility genes "SCN5A-SCN10A" locus and effect the expression of SCN5A. 33 Hey2 has been recently shown to be a BrS susceptibility gene by modulating cardiac transmural ion channel patterning and electrical heterogeneity. 32 In addition, activation of canonical Wnt signaling has been shown to decrease SCN5A mRNA levels, Na v 1.5 protein and Na + current density in rat ventricular myocytes. 34 The putative mutations in BrS susceptibility genes (e.g., SCN5A, SCN10A, SCN4A, SCNN1A, KCNJ8, and KCND3) identified in this study likely contribute to the DI-type 1 BrP, although further study is needed to reach this conclusion.
Study limitations
The follow-up period was short and therefore we are not able to report the long-term outcomes. None of the patients had history of cardiac arrest in our study population. Patients with WPW syndrome and WPW "pattern" had different degrees of cardiac memory after catheter ablation at the time of ajmaline challenge tests. The interpretation of the ajmaline challenge was not performed in a blinded fashion in the study. Additional functional expression studies are needed to ascertain the degree to which the novel mutations uncovered lead to loss of function of inward current or gain of function of outward currents known to predispose to the J-Wave syndromes.
CONCLUSIONS
DI-type 1 BrP is relatively common in patients with AV-APs. We identify 12-lead ECG characteristics during preexcitation and orthodromic
AVRT that point to the presence of underlying type 1 BrP. Because of the lack of long-term follow-up, we are unable to determine definitively whether patients with DI-Type 1 BrP and AV-APs are more or less prone to develop AF.
